Review: Artificial liver support systems

Biotechnology and Bioengineering

Volumn 50, Issue 4, 1996, Pages 382-391

  Kamlot, Andreas ^a   Rozga, Jacek ^a   Watanabe, Frederick D ^a   Demetriou, Achilles A ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

artificial organs; hepatic encephalopathy; liver

Indexed keywords

BIOLOGICAL MATERIALS; BIOMEDICAL ENGINEERING; BIOMEDICAL EQUIPMENT; DISEASES; PATIENT TREATMENT; TISSUE CULTURE; TRANSPLANTATION (SURGICAL);

CHRONIC LIVER DISEASE; EXACERBATION; FULMINANT HEPATIC FAILURE; HEPATIC ENCEPHALOPATHY; HEPATOCYTE; LIVER; LIVER SUPPORT SYSTEMS; SPECIFIC THERAPEUTIC MODALITIES;

ARTIFICIAL ORGANS;

ARTIFICIAL LIVER; BIOREACTOR; CLINICAL TRIAL; HEMOPERFUSION; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CELL; LIVER FAILURE; LIVER TRANSPLANTATION; PLASMAPHERESIS; REVIEW;

EID: 15844375660     PISSN: 00063592     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0290(19960520)50:4<382::AID-BIT5>3.0.CO;2-H     Document Type: Review

References (88)

1. Abouna, G. M., Serrou, B., Boehming, H. G., et al. 1970. Long-term hepatic support by intermittent multi-species liver perfusion. Lancet ii: 391-396.
2. Abouna, G. M., Cook, J. S., Fisher, L. M., et al. 1972. Treatment of acute hepatic coma by ex vivo baboon and human liver perfusion. Surgery 71: 537-547.
3. Ascher, N. L., Lake, J. R., Emond, J. C., et al. 1993. Liver transplantation for fulminant hepatic failure. Arch. Surg. 128: 677-682.
4. Bader, A., Knop, E., Boker, K., et al. 1995. A novel bioreactor design for in vitro reconstruction of in vivo liver characteristics. ASAIO J. 19: 368-374.
5. Bernuau, J,. Benhamou, J. P. 1991. Fulminant and subfulminant liver failure, pp. 923-423. In: N. McIntyre, J. F. Benhamou, J. Bircher, M. Rizzetto, and J. Rodes (eds.), Oxford textbook of clinical hepatology. Oxford University Press, New York.
6. Bihari, D., Hughes, R. D., Gimson, A. E. S. et al. 1983. Effects of serial resin hemoperfusion in fulminant hepatic failure. Int. J. Artif. Org. 6: 299-302.
7. Burnell, J. M., Dawborn, J. K., Epstein, M. D., et al. 1967. Acute hepatic coma treated by cross circulation or exchange transfusion. N. Engl. J. Med. 276: 935-943.
8. Brunner, G., Holloway, C. J., Losgen, H. 1979. The application of immobilized enzymes in an artificial liver support system. Artif. Org. 3: 27-30.
9. Chang, T. M. S. 1972. Haemoperfusion over a microencapsulated adsorbent in a patient with hepatic coma. Lancet ii: 1371-1372.
10. Chang, T. M. S. 1980. Clinical experience with ACAC coated charcoal hemoperfusion in acute intoxication. Clin. Toxicol. 17: 529-542.
11. Chari, R. S., Collins, B. H., Magee, J. C., et al. 1994. Brief report: Treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation. N. Engl. J. Med. 331: 234-237.
12. Cohen, C., Benjamin, M. 1991. Alcoholics and liver transplantation. JAMA 265: 1299-1301.
13. Cooper, G. N., Karlson, K. E., Clowes, G. H. A., et al. 1977. Total body washout and exchange. A valuable tool in acute hepatic coma and Reye's syndrome. Am. J. Surg. 133: 522-530.
14. Czaja, A. J. 1985. Fulminant hepatitis: Room for improvement. Mayo Clin. Proc. 60: 348-350.
15. Demetriou, A. A., Reisner, A. Sanchez, J., et al. 1988. Transplantation of microcarrier-attached hepatocytes into 90% partially hepatectomized rats. Hepatology 8: 1006-1009.
16. Denis, J., Opolon, P., Nusinovici, V., et al. 1978. Treatment of encephalopathy during fulminant hepatic failure by hemodialysis with high permeability membrane. Gut 19: 787-793.
17. Denti, E., Luboz, M. P. 1974. Preparation and properties of gelentrapped liver cell microsomes, pp. 148-152. In: R. Williams and I. M. Murray-Lyon (eds.). Artificial liver support. Pitman Medical, Kent, UK.
18. Eiseman, B., Liem, D. S., Raffucci, F. 1965. Heterologous liver perfusion in treatment of hepatic failure. Ann. Surg. 162:329-345.
19. Eiseman, B., Norton, L., Kralios, N. C. 1976. Hepatocyteperfusion within a centrifug. Surg. Gynecol. Obstet. 142: 21-28.
20. Fox, I. J., Langnas, A. N., Ozaki, C. F., et al. 1992. Successful application of extracorporeal liver perfusion for the treatment of fulminant hepatic failure: A technology whose time has come [abstract]. Hepatology 16: 88A.
21. Fremond, B., Malandain, C., Guyomard, C., et al. 1993. Correction of bilirubin conjugation in the Gunn rat using hepatocytes immobilized in alginate gel beads as an extracorporeal bioartificial liver. Cell Transplant. 2: 453-460.
22. Gazzard, B. G., Weston, M. J., Murray-Lyon, I. M., et al. 1974. Charcoal hemoperfusion in the treatment of fulminant hepatic failure. Lancet i: 1301-1307.
23. Gelfand, M. C., Wincester, J. F., Knepshield, J. H., et al. 1978. Biochemical correlates of reversal of hepatic coma with coated charcoal hemoperfusion. Trans. Am. Soc. Artif. Intern. Org. 24: 239-242.
24. Gerlach, J., Schnoy, N., Smith, M. D., et al. 1994. Hepatocyte culture between woven capillar networks. A microscopy study. Artif. Org. 18: 226-30.
25. Gerlach, J., Jorres, A., Trost, O., et al. 1993. Side effects of hybrid liver support therapy: TNF-α liberation in pigs associated with extracorporeal bioreactors. Int. J. Artif. Org. 16: 604-608.
26. Gimson, A. E. S., Mellon, P. J., Braude, S., et al. 1982. Earlier charcoal haemoperfusion in fulminant hepatic failure. Lancet ii: 681-683.
27. Gove, C. D., Hughes, R., Williams, R. 1982. Rapid inhibition of DNA synthesis in hepatocytes from regenerating rat livers by serum from patients with fulminant hepatic failure. Br. J. Exp. Pathol. 63: 547-561.
28. Haapanen, E., Tiula, E. 1972. Plasmapheresis with albumin as main substitute in acute hepatic coma. Scand. J. Gastroenterol. 7: 75-83.
29. Hager, J. C., Carman, R., Stoller, R., et al. 1978. A prototype for a hybrid artificial liver. Trans. Am. Soc. Artif. Intern. Org. 24: 250-253.
30. Hager, J. C., Carman, R., Porter, L. E., et al. 1983. Neonatal hepatocyte culture on artificial capillaries: A model for drug metabolism and the artificial liver. ASAIO J. 6: 26-35.
31. Hori, M. 1982. Artificial liver: The concept and working hypothesis of hybrid organs: From a 25-year-old anecdote to the 21st century model. Trans. Am. Soc. Artif. Intern. Org. 18: 639-641.
32. Inoue, N., Yamazaki, Z., Yoshiba, M., et al. 1981. Membrane plasmapheresis with plasma exchange in the treatment of acute liver failure. Artif. Org. 5: 851-853.
33. Jauregui, H. O., Naik, S., Driscoll, J., et al. 1984. Adult rat hepatocyte cultures as the cellular component of an artificial hybrid liver, pp 130-140. In: J. P. Paul, J. D. S. Galor, J. M. Courtney, and T. Gilchrist (eds.), Biomaterials in artificial organs. Macmillan, London.
34. National Center for Health Statistics. 1990. MOA. Vitel. Stat. Rep. 39: 1-14.
35. Jones, E. A. Schafer, D. F. 1990. Fulminant hepatic failure, pp. 460-492. In: D. Zakim and T. D. Boyer (eds.), Hepatology. Saunders, Philadelphia.
36. Juggi, J. S. 1973. Extracorporeal cation-exchange circuits in the treatment of hyperammonemia of hepatic failure. Med. J. Aust. 60: 926-930.
37. Kawamura, A., Takahashi, T., Kusumoto, K., et al. 1985. The development of a new hybrid support system using frozen liver pieces (FLP). Jpn. J. Artif. Org. 14: 253-257.
38. Kiley, J. E., Pender, J. C., Welch, H. F., et al. 1958. Ammonia intoxication treated with hemodialysis. N. Engl. J. Med. 259:1156-1161.
39. Kimoto, S. 1959. The artificial liver experiments and clinical application. ASAIO Trans. 5: 102-110.
40. Lee. C, Tink, A. 1958. Exchange transfusion in hepatic coma: Report of a case. Med. J. Aust. 1: 40-42.
41. Lee, W. M. 1993. Acute liver failure. N. Engl. J. Med. 329: 1862-1868.
42. Li, A. P., Barker, G., Beck, D., et al. 1993. Culturing of primary hepatocytes as entrapped aggregates in a packed bed bioreactor: A potential bioartificial liver. In Vitro Cell. Dev. Biol. 29A: 249-254.
43. Lie, T. S., Jung, V., Kachel, F., et al. 1985. Successful treatment of hepatic coma by a new artificial liver device in the pig. Res. Exp. Med. 185: 483-494.
44. Margulis, M. S., Erukhimov, E. A. Andreiman, L. A., et al. 1989. Temporary organ substitution by hemoperfusion through suspension of active donor hepatocytes in a total complex of intensive therapy in patients with acute hepatic insufficiency. Resuscitation 18: 85-94.
45. Matsumura, K. N., Guevara, G. R., Huston, H., et al. 1987. Hybrid bioartificial liver in hepatic failure: Preliminary clinical report. Surgery 101: 99-103.
46. Miyoshi, H., Yanagi, K., Fukuda, H., et al. 1994. Long-term continuous culture of hepatocytes in a packed-bed reactor utilizing porous resin. Biotechnol. Bioeng. 43: 635-644.
47. Munoz, S. J., Ballas, S. K., Moritz, M. J., et al. 1989. Perioperative management of fulminant and subfulminant hepatic failure with therapeutic plasmapheresis. Transplant. Proc. 21: 3535-3536.
48. Nose, Y, Mikami, J., Kasai, Y., et at. 1963. An experimental artificial liver utilizing extracorporeal metabolism with slices or granulated canine liver. Trans. Am. Soc. Artif. Intern. Org. 9: 358-362.
49. Nyberg, S. L., Shatford, R. A., Peshwa, M. V., et al. 1993. Evaluation of a hepatocyte-entrapment hollow-fiber bioreactor: A potential bioartificial liver. Biotechnol. Bioeng. 41: 194-203.
50. Nyberg, S. L., Mann, H. J., Remmel, R. P., Hu, W.-S., Cerra, F. B. 1993. Pharmacokinetic analysis verifies P450 function during in vitro and in vivo application of a bioartificial liver. ASAIO J. 39: M252-M256.
51. Nyberg, S. L., Payne, W. D., Amiot, B., Shirabe, K., Remmel, R. P., Hu, W.-S., Cerra, F. B. 1993. Demonstration of biochemical function by extracorporeal xenohepatocytes in an anhepatic animal model. Transplant. Proc. 25: 1994-1945.
52. Nyberg, S. L., Remmel, R. P., Mann, H. J., et al. 1994. Primary hepatocytes outperform HepG2 cells as the source of biotransformation functions in a bioartificial liver. Ann. Surg. 220: 59-67.
53. O'Grady, J. G., Gimson, A. E., O'Brien, C. J., et al. 1988. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology. 94: 1186-1192.
54. Olumide, F., Eliashiv, A., Kralios, N., et al. 1977. Hepatic support with hepatocyte suspensions in a permeable membrane dialyzer. Surgery 82: 599-606.
55. Opolon, P., Rapin, J. R., Huguet, C., et al. 1976. Hepatic failure coma treated by polyacrylonitrile membrane hemodialysis. Trans. Am. Soc. Artif. Intern. Org. 22: 701-710.
56. Parbhoo, S. P., James, I. M., Ajdukiewicz, A., et al. 1971. Extracorporal pig-liver perfusion in treatment of hepatic coma due to fulminant hepatitis. Lancet ii: 659-665.
57. Rakela, J., Kurzt, S. B., McCarthy, J. T., et al. 1988. Postdilution hemofiltration in the management of acute hepatic failure: A pilot study. Mayo Clin. Proc. 63: 113-118.
58. Redeker, A. G., Yamahiro, H. S. 1973. Controlled trial of exchange-transfusion therapy in fulminant hepatitis. Lancet i: 3-6.
59. Roberts, E. A., Letarte, M., Squire, J., Yang, S. 1994. Characterization of human hepatocyte lines derived from normal liver tissue. Hepatology 19: 1390-1399.
60. Rozga, J., Williams, F., Ro, M.-S., et al. 1993. Development of a bioartificial liver: Properties and function of a hollow-fiber module inoculated with liver cells. Hepatology 17: 258-265.
61. Rozga, J., Holzman, M. D., Ro M.-S., et al. 1993. Hybrid bioartificial liver support treatment of animals with severe ischemic liver failure. Ann. Surg. 217: 502-511.
62. Rozga, J., Podesta, L., LePage, E., et al. 1993. Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure. Lancet 342: 898-899.
63. Rozga, J., LePage, E., Moscioni, A D., et al. 1994. Clinical use of a bioartificial liver to treat fulminant hepatic failure. Ann. Surg 219: 538-546.
64. Rozga, J., Kong, L. B., Morsiani, E., et al. 1994. Matrix-induced liver cell aggregates (MILCA) for artificial liver [abstract]. Hepatology 20: 140A.
65. Sabin, S., Merritt, J. A. 1968. Treatment of hepatic coma in cirrhosis by plasmapheresis and plasma infusion (plasma exchange). Ann. Intern, med. 68: 1-7.
66. Saito, S., Sakagami, K., Orita, K. 1987. A new hybrid artificial liver using a combination of hepatocytes and biomatrix. Trans. Am. Soc. Artif. Intern. Org. 33: 459-462.
67. Schechter, D. C., Nealon, T. F., Gibbon, J. H. 1958. A simple extracorporeal device for reducing elevated blood ammonia levels. Surgery 44: 892-897.
68. Sen, P. K., Bhalerao, R. A., Parulkar, G. P., et al. 1966. Use of perfused cadaveric liver in the management of hepatic failure. Surgery 59: 774-781.
69. Shibusawa, K., Tago, J. 1956. Artificial kidney. Saishin Igaku 11: 298-310.
70. Sielaff, T. D., Hu, M. Y., Tollins, M. D., et al. 1994 Characterization and function of the porcine hepatocyte gel-entrapment bioartificial liver [abstract]. Hepatology 20: 140A.
71. Silk, D. B. A., Trewby, P. N., Chase, R. A., et al. 1977. Treatment of fulminant hepatic failure by polyacrylonitrile-membrane hemodialysis. Lancet ii: 1-3.
72. Sorrentino, F. Prime ricerche per la realizzatione di un fegato artificiale. 1956. Chir. Patol. Sper. 4:1401-1414.
73. Soyer, T., Lempinen, M., Walker, J. E., et al. 1973. Extracorporeal assist of anhepatic animals with liver slice perfusion. Am. J. Surg. 126: 20-24.
74. Sussman, N. L., Chong, M. G., Koussayir, T., et al. 1992. Reversal of fulminant hepatic failure using an extracorporeal liver assist device. Hepatology 16: 60-65.
75. Sussman, N. L., Kelly, J. H. 1993. Improved liver function following treatment with an extracorporeal liver assist device. Trans. Am. Soc. Artif. Intern. Org. 17: 27-30.
76. Takahashi, M., Matsue, M., Matsushita, M., et al. 1992. Does porcine hepatocyte hybrid artifical liver prolong the survial time of anhepatic rabbits? ASAIO J. 38: M468-M472.
77. Takahashi, I., Otsubo, O., Inoue, T. Y., et al. 1981. Hepatic support system with isolated liver cells. Artif. Org. 10: 537-540.
78. Trey, M.B., Burns, D.G., Saunders, S. J. 1966. Treatment of hepatic coma by exchange blood transfusion. N. Engl. J. Med. 274: 473-481.
79. Trey, C., Davidson, C. 1970. The management of fulminant hepatic failure, pp. 282-298. In: H. Popper and F. Schaffner (eds.). Progress in liver disease. Grune & Stratton, New York.
80. Uchino, J., Tsuburaya, T., Kumagai, F., et al 1988. A hybrid bioartificial liver composed of multiplated hepatocyte monolayers. ASAIO Trans. 34: 972-977.
81. Usami, M., Ohyanagi, H., Nishimatsu, S., Kasahara, H., et al. 1989. Therapeutic plasmapheresis for liver failure after hepatectomy. ASAIO Trans. 35: 564-567.
82. Wada, G., Oshima, N. 1985. Improvement of the performance of a hybrid-type artificial liver utilizing isolated hepatocytes: The use of conditioned medium. Jpn. J. Artif. Org. 14: 241-44.
83. Wendon, J., Hughes, R., Langley, P., et al. 1994. A controlled trial of the Hepatix extracorporeal liver assist device (ELAD) in acute liver failure [abstract]. Hepatology 20: 140A.
84. Williams, R., Wendon, J. 1994. Indications for orthotopic liver transplantation in fulminant liver failure. Hepatology 20: 5S-10S.
85. Winikoff, S., Glassman, M. S., Spivak, W. 1985. Plasmapheresis in a patient with hepatic failure awaiting liver transplantation. J. Pediatr. 107: 547-549.
86. Wolf, C. F. W., Munkelt, B. E. 1975. Bilirubin conjugation by an artificial liver composed of cultured cells and synthetic capillaries. Trans. Am. Soc. Artif. Org. 21: 16-26.
87. Yanagi, K., Ookawa, K., Mizuno S., et al. 1989. Performance of a new hybrid artificial liver support system using hepactocytes entrapped within a hydrogel. Trans. Am. Sec. Artif. Intern. Org. 35: 570-572.
88. Yatzidis, H. The charcoal artificial kidney in clinical practice. Paper presented at the Cleveland Clinic Foundation. Cleveland, OH, October 18, 1966.